Colorcon Ventures

Strategic Investments for Lasting Impact

Colorcon Ventures invests in innovative solutions within the pharmaceutical and nutraceutical industries, with a focus on technologies that improve patient compliance, and support the authentication of dosage forms to combat counterfeiting.

We are particularly interested in transformational technologies that disrupt traditional dosage delivery methods, as well as smart solutions for digital and personalized medicine. Our portfolio also includes breakthrough manufacturing innovations and intelligent systems that address unmet needs across pharmaceutical technologies and supply chains. In addition to funding, we provide strategic support through commercial consultation, along with guidance on sales and scientific development to help our portfolio companies grow.

(Please note that we do not invest in active pharmaceutical ingredients (API) or therapeutic molecule development.)

Where We Invest

Focused primarily on early and mid-stage investments

Seeking startups with product-market fit and revenue growth

Aligned with Colorcon’s expertise in pharma and nutra innovation

How We Invest

$50M fund dedicated to pharma and nutra advancements

Initial investments of $0.5-2.5M

Reserved capital for follow-on funding

Co-investing with top-tier VC firms

Our Growing Profile

Stealth
Offering a platform technology for oral therapies that target specific tissues, leading to better outcomes through increased bioavailability and higher efficacy for unmet conditions.

Visit Syntis Bio
Through developing advanced Artificial Intelligence and Machine Learning solutions, Atomwise helps pharmaceutical industry overcome the challenges of drug discovery and create better medicines faster.

Visit Atomwise
Replacing the Syringe with a Pill, i2O Therapeutics has developed a disruptive ionic liquid technology that enables oral delivery of biologics and other injection-based drugs. The ability to deliver injectable therapies orally has the potential to significantly improve patient adherence and outcomes.

Visit i2O Therapeutics
Leading provider of personalized 3D printed chewable nutritional gummies with a clean ingredient profile, Remedy leverages its patented 3D-printing technology to produce gummy vitamin stacks that are enjoyable and convenient to take as a single oral dose.

Visit Remedy Health
Through its bio-simulation platform, VeriSIM Life enables the pharmaceutical industry to narrow down most efficacious compounds, de-risk R&D decisions, predict preclinical outcomes prior to human trials, reduce animal testing and therefore facilitating speed to market at a lower cost.

Visit Verism Life
From small and large molecules to cell and gene therapy, solid oral dosages to injectables and beyond, Apprentice leverages artificial intelligence and augmented reality to get medicine to patients faster.

Visit Apprentice
Innovative clinical nutrition company, operating at the intersection of Nutra, Pharma and Digital wellness, providing value-based care and a data driven solution, focusing on patient engagement and adherence.

Vist Mend
Leading developer of a new class of therapeutics to modulate human microbiome based on rational design of defined consortia of bacteria that are essential for gut health.

Visit Vedanta
Exited
Stealth
Offering a platform technology for oral therapies that target specific tissues, leading to better outcomes through increased bioavailability and higher efficacy for unmet conditions.

Visit Syntis Bio

The Team

Bringing together expertise to drive innovation and growth.

Industry-leading expertise in pharmaceutical excipients, coating systems, and modified release technologies. Our team brings decades of experience in transforming pharmaceutical development and manufacturing.

Visit Colorcon

A trusted partner in corporate venture capital, Cerity Partners brings a wealth of experience in helping companies scale through strategic investments and operational support. Together, we maximize value for startups in the pharma space.

Visit Cerity Partners